VigoreMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: people who want a simple one-time-purchase compounded GLP-1 plan with a dedicated coach and no subscription
VigoreMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on disclosure. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked November 2026
VigoreMD is a Florida telehealth brand, launched in 2026, that sells two compounded GLP-1 programs with a dedicated care coach: a daily semaglutide dissolving tablet for $199 a month and weekly tirzepatide injections for $299. Each order is a one-time purchase with no subscription. Clinicians come from its pharmacy partner's prescriber network, and neither the pharmacy nor the prescribers are named.
Is VigoreMD legit?
Yes. VigoreMD is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a VigoreMD promo or coupon code?
We know of no promo or coupon code for VigoreMD. Its listed price is $199 a month. Coupon sites advertising "VigoreMD discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how VigoreMD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to VigoreMD
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
VigoreMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 46 states
- FDA status
- No FDA warning letters found
How VigoreMD scores
Six columns, each one computed from something VigoreMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.4/10Serves 46 of 50 states.
Support10%
8.5/10The price covers the medication, clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on VigoreMD
Last checked November 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: 46 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for VigoreMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with VigoreMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1VigoreMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask VigoreMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- VigoreMD serves 46 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting VigoreMD
- Phone
- 1-833-844-6735
- VigoreMD offers email support
Cancelling VigoreMD
Taken from the terms VigoreMD publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; terms: "VigoréMD does not sell subscriptions. There is no membership fee, no long-term commitment, and no automatic renewal." Multi-month quantities, where offered, are paid in full at checkout and do not renew
- Refund policy
- Terms 5: "If the clinician determines that treatment is not appropriate for you, your order is not fulfilled and your payment is refunded in full." "Because medications are personalized and shipped, refunds after a prescription has been dispensed are limited and evaluated case by case."
- Early-termination fee
- None
Medications VigoreMD lists
VigoreMD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Programs page: "Vigoré Spark SEMAGLUTIDE 1.5MG ODT · DAILY ORAL ... 30-day supply · 30 tablets $199". Terms: "Each order is a separate, one-time purchase".
Programs page: "Vigoré Apex TIRZEPATIDE 10MG/ML · ONCE-WEEKLY ... $299". The supply length per order is not stated.
Check the price yourself before you pay
Every figure here comes from VigoreMD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 46 states
- We found no FDA warning letters issued to VigoreMD
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What VigoreMD charges
VigoreMD lists $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so VigoreMD's $199 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare VigoreMD's cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What VigoreMD dispenses
VigoreMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at VigoreMD at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
VigoreMD tells you its price before you start the medical questionnaire and the 46 states it serves. It also offers coaching as part of the plan. We found no FDA warning letters issued to VigoreMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If VigoreMD will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether VigoreMD bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
- you want coaching bundled in rather than billed on top
Our read
VigoreMD lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
VigoreMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on disclosure. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Before you pay VigoreMD
Starting at $199 a month. Check today's price, then start the intake.
Where VigoreMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to VigoreMD sets more sellers in the same category beside VigoreMD on price, states and what the price includes.
Frequently Asked Questions
How to check VigoreMD yourself
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Massachusetts, Michigan, Minnesota, New Hampshire, North Carolina, Oregon, Virginia, Wyoming and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this VigoreMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See VigoreMD's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.